公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2022 | APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis | You H.; Ma X.; Efe C.; Wang G.; Jeong S.-H.; Abe K.; Duan W.; Chen S.; Kong Y.; Zhang D.; Wei L.; Wang F.-S.; Lin H.-C.; Yang J.M.; Tanwandee T.; Gani R.A.; Payawal D.A.; Sharma B.C.; Hou J.; Yokosuka O.; Dokmeci A.K.; Crawford D.; JIA-HORNG KAO ; Piratvisuth T.; Suh D.J.; Lesmana L.A.; Sollano J.; Lau G.; Sarin S.K.; Omata M.; Tanaka A.; Jia J. | Hepatology International | 42 | 19 | |
2021 | APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy | Lau G.; Yu M.-L.; Wong G.; Thompson A.; Ghazinian H.; Hou J.-L.; Piratvisuth T.; Jia J.-D.; Mizokami M.; Cheng G.; Chen G.-F.; Liu Z.-W.; Baatarkhuu O.; ANN-LII CHENG ; Ng W.L.; Lau P.; Mok T.; Chang J.-M.; Hamid S.; Dokmeci A.K.; Gani R.A.; Payawal D.A.; Chow P.; Park J.-W.; Strasser S.I.; Mohamed R.; Win K.M.; Tawesak T.; Sarin S.K.; Omata M. | Hepatology International | 52 | 41 | |
2016 | Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update | Sarin S.K.; Kumar M.; Lau G.K.; Abbas Z.; Chan H.L.Y.; Chen C.J.; DING-SHINN CHEN ; HUEY-LING CHEN ; PEI-JER CHEN ; Chien R.N.; Dokmeci A.K.; Gane E.; Hou J.L.; Jafri W.; Jia J.; Kim J.H.; Lai C.L.; Lee H.C.; Lim S.G.; CHUN-JEN LIU ; Locarnini S.; Al Mahtab M.; Mohamed R.; Omata M.; Park J.; Piratvisuth T.; Sharma B.C.; Sollano J.; Wang F.S.; Wei L.; Yuen M.F.; Zheng S.S.; JIA-HORNG KAO | Hepatology International | 1872 | 1662 | |
2005 | Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2005 update | Liaw Y.-F.; Leung N.; Guan R.; Lau G.K.K.; Merican I.; McCaughan G.; Gane E.; JIA-HORNG KAO ; Omata M.; Chutaputti B.A.; DING-SHINN CHEN ; Chien R.N.; Cooksley G.; Han K.H.; Ichida T.; Lai M.Y.; Lesmana L.; Piratvisuth T.; Sarin S.K.; Sollano J.; Suh D.J.; Yao G.B.; Yeh C.T.; Yokosuka O. | Liver International | 334 | 271 | |
2008 | Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2008 update | Liaw Y.-F.; Leung N.; JIA-HORNG KAO ; Piratvisuth T.; Gane E.; Han K.-H.; Guan R.; Lau G.K.K.; Locarnini S. | Hepatology International | 836 | 748 | |
2012 | Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update | Liaw Y.-F.; JIA-HORNG KAO ; Piratvisuth T.; Chan H.L.Y.; Chien R.-N.; CHUN-JEN LIU ; Gane E.; Locarnini S.; Lim S.-G.; Han K.-H.; Amarapurkar D.; Cooksley G.; Jafri W.; Mohamed R.; Hou J.-L.; Chuang W.-L.; Lesmana L.A.; Sollano J.D.; Suh D.-J.; Omata M. | Hepatology International | 835 | 785 | |
2010 | Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions | Ahn S.H.; Chan H.L.Y.; PEI-JER CHEN ; Cheng J.; Goenka M.K.; Hou J.; Lim S.G.; Omata M.; Piratvisuth T.; Xie Q.; Yim H.J.; Yuen M.-F. | Hepatology International | 38 | 41 | |
2014 | Consensus cost-effectiveness model for treatment of chronic hepatitis B in Asia Pacific countries | Dan Y.Y.; Wong J.B.; Hamid S.S.; Han K.-H.; Jia J.D.; CHUN-JEN LIU ; Piratvisuth T.; Lok A.S.F.; Lim S.G. | Hepatology International | 10 | 8 | |
2010 | Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy | Lui Y.Y.-N.; Tsoi K.K.-F.; Wong V.W.-S.; JIA-HORNG KAO ; Hou J.-L.; Teo E.-K.; Mohamed R.; Piratvisuth T.; Han K.-H.; Mihm U.; Wong G.L.-H.; Chan H.L.-Y. | Antiviral Therapy | 35 | 37 | |
2012 | Erratum: Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update (Hepatology International (2012) 6 (531-561) DOI: 10.1007/s12072-012-9365-4) | Liaw Y.-F.; JIA-HORNG KAO ; Piratvisuth T.; Chan H.L.Y.; Chien R.-N.; CHUN-JEN LIU ; Gane E.; Locarnini S.; Lim S.-G.; Han K.-H.; Amarapurkar D.; Cooksley G.; Jafri W.; Mohamed R.; Hou J.-L.; Chuang W.-L.; Lesmana L.A.; Sollano J.D.; Suh D.-J.; Omata M. | Hepatology International | 16 | 18 | |
2019 | Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B | Wei L.; Pavlovic V.; Bansal A.T.; Chen X.; Foster G.R.; He H.; JIA-HORNG KAO ; Lampertico P.; Liaw Y.-F.; Motoc A.; Papatheodoridis G.V.; Piratvisuth T.; Plesniak R.; Wat C. | Journal of Viral Hepatitis | 2 | 2 | |
2011 | Hepatitis B surface antigen quantification: Why and how to use it in 2011 - A core group report | Chan H.L.-Y.; Thompson A.; Martinot-Peignoux M.; Piratvisuth T.; Cornberg M.; Brunetto M.R.; Tillmann H.L.; JIA-HORNG KAO ; Jia J.-D.; Wedemeyer H.; Locarnini S.; Janssen H.L.A.; Marcellin P. | Journal of Hepatology | 274 | 247 | |
2017 | Management of hepatitis C virus infection in the Asia-Pacific region: an update | Lim S.G.; Aghemo A.; PEI-JER CHEN ; Dan Y.Y.; Gane E.; Gani R.; Gish R.G.; Guan R.; Jia J.D.; Lim K.; Piratvisuth T.; Shah S.; Shiffman M.L.; Tacke F.; Tan S.S.; Tanwandee T.; Win K.M.; Yurdaydin C. | The Lancet Gastroenterology and Hepatology | 48 | 43 | |
2019 | Peginterferon alfa-2a (40 kD) stopping rules in chronic hepatitis B: A systematic review and meta-analysis of individual participant data | Pavlovic V.; Yang L.; Chan H.L.-Y.; Hou J.; Janssen H.L.; JIA-HORNG KAO ; Lampertico P.; Peng C.-Y.; Piratvisuth T.; Thompson A.J.; Wedemeyer H.; Wei L.; Wat C. | Antiviral Therapy | 10 | 7 | |
2015 | Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection | Colvin R.A.; Tanwandee T.; Piratvisuth T.; Thongsawat S.; Hui A.J.; Zhang H.; Ren H.; PEI-JER CHEN ; Chuang W.-L.; Sobhonslidsuk A.; Li R.; Qi Y.; Praestgaard J.; Han Y.; Xu J.; Stein D.S.; Chien R.-N.; Flisiak R.; Jablkowski M.; Liaw Y.-F.; Sung J.J.-Y. | Journal of Gastroenterology and Hepatology (Australia) | 6 | 6 | |
2015 | Reimbursement policies in the Asia-Pacific for chronic hepatitis B | Lim S.G.; Amarapurkar D.N.; Chan H.L.-Y.; Crawford D.H.; Gane E.J.; Han K.-H.; Ahn S.H.; Jafri W.; Jia J.; JIA-HORNG KAO ; Lesmana L.A.; Lesmana C.R.A.; Mohamed R.; Phiet P.H.; Piratvisuth T.; Sarin S.K.; Sollarno J.D.; Eguchi Y.; Mahtab M.-A.; Lee K.H. | Hepatology International | 21 | 19 | |
2011 | A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt | Sievert W.; Altraif I.; Razavi H.A.; Abdo A.; Ahmed E.A.; Alomair A.; Amarapurkar D.; CHIEN-HUNG CHEN ; Dou X.; El Khayat H.; elShazly M.; Esmat G.; Guan R.; Han K.-H.; Koike K.; Largen A.; Mccaughan G.; Mogawer S.; Monis A.; Nawaz A.; Piratvisuth T.; Sanai F.M.; Sharara A.I.; Sibbel S.; Sood A.; Suh D.J.; Wallace C.; Young K.; Negro F. | Liver International | 444 | 416 | |
2010 | Treatment of chronic hepatitis B in Asia-Pacific countries: Is the Asia-Pacific consensus statement being followed? | Sung J.J.Y.; Amarapurkar D.; Chan H.L.Y.; Cheng J.; JIA-HORNG KAO ; Han K.-H.; Piratvisuth T. | Antiviral Therapy | 9 | 9 |